GLP-1s and Your Period: Cycle Changes, Spotting, and When to Call Your Doctor

The FDA labels say little about periods directly, but they say a lot about birth control and pregnancy. Here is what is known, what is still anecdote, and which changes need a call to your clinician.

4 weeks Tirzepatide's label advises women on birth control pills to switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase. A cycle change on a GLP-1 can mean returning ovulation, so pregnancy should be on your list of possibilities.

Yes, a lot of women notice their period changing after starting a GLP-1 such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound): a cycle that arrives earlier or later, a lighter or heavier flow, spotting between periods, or a period that returns after months away. The FDA labels don't list menstrual changes as a common side effect, so most of what women describe hasn't been measured in trials. The most likely explanation for many changes is the weight loss itself, which can shift hormones and restart ovulation. That is good news for some women and a surprise pregnancy risk for others.

What the labels actually say

Neither the Zepbound nor the Wegovy prescribing information lists irregular periods among its common adverse reactions. Both labels do contain guidance that matters for anyone with a cycle:

If you take the pill, read your own drug's label or ask the pharmacist. The guidance is not identical across GLP-1s.

Why your cycle might change

Weight loss can restart ovulation

Fat tissue makes and converts hormones, and excess weight is linked to insulin resistance, which can disrupt ovulation, especially in women with PCOS. When weight falls and insulin sensitivity improves, cycles that were irregular or absent can become more regular, and ovulation can return. That is the logic behind the "Ozempic baby" stories, which we cover in more detail in our guide to GLP-1s and fertility. If your periods were irregular before and are now arriving on a pattern, that may be the reason.

Fast weight loss and lower intake are stressors

The opposite can happen too. Eating much less than usual, losing weight quickly, or intense new exercise can suppress the hormonal signals that drive ovulation. For some women that shows up as a late, light or skipped period. If your appetite has dropped sharply, this is worth raising with your prescriber.

GI side effects can affect the pill

Nausea, vomiting and diarrhea are the most common side effects in the first weeks of treatment and after dose increases. Vomiting or severe diarrhea soon after taking a birth control pill can mean less of it is absorbed, which can cause breakthrough bleeding and reduce protection. Your pill's own leaflet explains what to do after vomiting; check it rather than guessing.

Everything else that changes cycles

A GLP-1 often starts at the same time as other life changes: new exercise, less alcohol, better sleep, or a new contraceptive. Perimenopause is another common overlap. Cycles in your 40s naturally become less predictable, and it is easy to credit the GLP-1 for a change that would have happened anyway. Our cycle-phase guide explains what each phase of a typical cycle looks like, which can help you spot what is actually different.

What women commonly notice, sorted by what it probably means

What you noticePossible explanationsWhat to do
Periods becoming more regular after being irregularWeight loss and better insulin sensitivity restoring ovulationTreat it as a sign you may be fertile; review contraception
Late or missed periodPregnancy, under-eating, rapid loss, stress, perimenopauseTake a pregnancy test first; then talk to your clinician
Spotting between periodsPill absorbed poorly after vomiting or diarrhea, missed pills, hormonal shiftsCheck your pill instructions; use backup contraception; mention it if it continues
Heavier or longer bleedingOvulatory cycles returning, fibroids, polyps, other causesCall if it is heavy (see red flags below) or keeps happening
Any bleeding after menopauseNeeds evaluation regardless of GLP-1 useBook an appointment; don't wait to see if it repeats

Red flags: when to call your doctor

Call your clinician promptly, or seek urgent care, if you have:

Book a routine visit if your cycle has changed for three months or more, if spotting keeps happening, or if you have new symptoms such as fatigue or hair shedding along with cycle changes. (If shedding is the issue, see our guide to GLP-1 hair shedding.)

Questions to ask your prescriber

Tracking helps more than guessing

Because so little of this has been measured, your own record is the best evidence you will have. A simple log of start dates, flow, spotting, missed pills, vomiting episodes and dose changes turns "my period's been weird" into something a clinician can act on. Note the date of each dose increase; the birth control guidance for tirzepatide and orforglipron centers on those windows.

A simple cycle log for GLP-1 users

Compounded and "research" GLP-1s

Everything above comes from the labels of FDA-approved products. Compounded semaglutide and tirzepatide are not FDA-approved, so there is no label of their own; prescribers generally apply the approved drugs' warnings, since the active ingredient is meant to be the same. Products sold online as "research use only" are not sold for human use at all, carry no label, and have no quality guarantee, which is one more reason unexplained bleeding or cycle changes on them deserve a clinician's attention. Our guide to compounded vs research vs prescribed peptides explains the differences.

If you're trying to conceive, or trying not to

If you don't want to be pregnant, assume a GLP-1 could make you more fertile, not less, and check that your contraception still works with your medication. If you are hoping to conceive, plan with your clinician before stopping. The 2-month washout on the Wegovy label is a starting point for that conversation, not the whole plan. Our hormonal balance hub collects the site's cycle, PCOS and fertility guides.

Prescription Option (Telehealth)

If you are considering a GLP-1 and have questions about cycles, contraception or pregnancy plans, raise them at the intake visit.

HealthRX offers prescription telehealth. A licensed clinician reviews your intake and decides whether a medication is appropriate. Compounded semaglutide is not FDA-approved, and results vary.

Visit HealthRX

Sources

  1. Eli Lilly. Zepbound (tirzepatide) prescribing information: oral hormonal contraceptives; pregnancy.
  2. Novo Nordisk. Wegovy (semaglutide) prescribing information: pregnancy and planned pregnancy.
  3. Eli Lilly press release via BioSpace. FDA approves Lilly's Foundayo (orforglipron), April 2026.

Frequently Asked Questions

Can Ozempic or Mounjaro change your period?
Many women report cycle changes, but the FDA labels don't list menstrual changes as a common side effect, so most reports are anecdotal. Weight loss can restore ovulation, while rapid loss and low food intake can suppress it, so cycles can shift in either direction.
Do GLP-1s make birth control pills less effective?
Tirzepatide's label says it may reduce the effectiveness of oral contraceptives and advises a non-oral or backup barrier method for 4 weeks after starting and after each dose increase. Lilly says the same for orforglipron (Foundayo) for 30 days. Check the label for your specific medication.
Is a late period on semaglutide a sign of pregnancy?
It can be. Weight loss can restart ovulation, so a late period on a GLP-1 should prompt a pregnancy test before you assume it is a side effect. If the test is positive, contact your prescriber about stopping the medication.
How long before trying to get pregnant should I stop Wegovy?
The Wegovy label advises stopping at least 2 months before a planned pregnancy because semaglutide stays in the body for a long time. Plan the timing with your clinician.
When should I call my doctor about period changes on a GLP-1?
Call promptly for very heavy bleeding, bleeding with dizziness or fainting, a positive pregnancy test, severe pelvic or abdominal pain, or any bleeding after menopause. Book a routine visit if changes last three months or more.

Related Reading

Medical Disclaimer: This article is for educational purposes only and is not medical advice. It is written by the FemPeptides editorial team from published research and is not reviewed by a clinician. Research-use-only peptides are not sold for human use. Talk to a licensed healthcare provider before starting, stopping or combining any treatment. Our editorial standards.
Affiliate Disclosure: FemPeptides earns commissions through some links on this page. This does not influence our evidence ratings or editorial content. Full disclosure →
Free Download

The Women's Peptide Guide

10 pages on peptides relevant to women's health and wellness goals, sourcing safely, and what to ask a provider.